AgomAb Therapeutics NV (AGMB)

AgomAb Therapeutics NV Statistics

Total Valuation

AGMB has a market cap or net worth of $545.36 million. The enterprise value is $410.04 million.

Market Cap	545.36M
Enterprise Value	410.04M

Important Dates

The last earnings date was Thursday, April 23, 2026, after market close.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	n/a

Share Statistics

AGMB has 48.74 million shares outstanding. The number of shares has increased by 2,064.50% in one year.

Current Share Class	n/a
Shares Outstanding	48.74M
Shares Change (YoY)	+2,064.50%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	26.19%
Float	25.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.15
P/TBV Ratio	4.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.52, with a Debt / Equity ratio of 0.01.

Current Ratio	6.52
Quick Ratio	6.27
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-445.68

Financial Efficiency

Return on equity (ROE) is -39.22% and return on invested capital (ROIC) is -23.03%.

Return on Equity (ROE)	-39.22%
Return on Assets (ROA)	-20.58%
Return on Invested Capital (ROIC)	-23.03%
Return on Capital Employed (ROCE)	-43.87%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.27M
Employee Count	58
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	12.48
200-Day Moving Average	n/a
Relative Strength Index (RSI)	49.25
Average Volume (20 Days)	168,747

Short Selling Information

The latest short interest is 433,265, so 0.89% of the outstanding shares have been sold short.

Short Interest	433,265
Short Previous Month	257,073
Short % of Shares Out	0.89%
Short % of Float	1.69%
Short Ratio (days to cover)	2.11

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-69.60M
Pretax Income	-73.44M
Net Income	-73.44M
EBITDA	-69.34M
EBIT	-69.60M
Earnings Per Share (EPS)	-$135.71

Balance Sheet

The company has $136.80 million in cash and $1.47 million in debt, with a net cash position of $135.33 million or $2.78 per share.

Cash & Cash Equivalents	136.80M
Total Debt	1.47M
Net Cash	135.33M
Net Cash Per Share	$2.78
Equity (Book Value)	153.69M
Book Value Per Share	73.56
Working Capital	120.52M

Cash Flow

In the last 12 months, operating cash flow was -$60.75 million and capital expenditures -$4,696, giving a free cash flow of -$60.68 million.

Operating Cash Flow	-60.75M
Capital Expenditures	-4,696
Depreciation & Amortization	256,801
Net Borrowing	-396,342
Free Cash Flow	-60.68M
FCF Per Share	-$1.24

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AGMB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2,064.50%
Shareholder Yield	-2,064.50%
Earnings Yield	-13.47%
FCF Yield	-11.13%

Analyst Forecast

The average price target for AGMB is $32.00, which is 185.71% higher than the current price. The consensus rating is "Buy".

Price Target	$32.00
Price Target Difference	185.71%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2